Hypertension Medications: Types, How They Work, and What to Expect

When lifestyle changes alone are not enough to bring blood pressure to target — or when the numbers are high enough that waiting poses risk — medication enters the picture. There are more than a dozen classes of antihypertensive drugs available, but five classes form the backbone of treatment. Each works through a different mechanism, and understanding those mechanisms helps explain why one drug may be chosen over another.

This is not a guide for self-prescribing. It is an overview to help you understand the medication your doctor recommends, ask better questions, and know what to expect.

First-Line Medications

The 2017 ACC/AHA guidelines identify four classes as appropriate first-line therapy for most adults with hypertension: thiazide diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers. The choice among them depends on the patient's age, race, kidney function, comorbidities, and tolerance of side effects.

Thiazide Diuretics

Thiazide and thiazide-like diuretics (chlorthalidone, hydrochlorothiazide, indapamide) work by preventing sodium reabsorption in the kidneys. When less sodium is reabsorbed, more water is excreted, reducing blood volume and, consequently, blood pressure. Over the long term, they also reduce peripheral vascular resistance through mechanisms that are not entirely understood.

Thiazides have been used since the 1950s and have the longest track record of any antihypertensive class. The ALLHAT trial, one of the largest hypertension studies ever conducted with over 33,000 participants, found that chlorthalidone was as effective as amlodipine (a calcium channel blocker) and lisinopril (an ACE inhibitor) at preventing major cardiovascular events, and superior for preventing heart failure.

Common side effects: Increased urination (usually resolves in a few weeks), low potassium, elevated uric acid, mild increases in blood glucose. Potassium levels should be monitored, particularly in patients also taking digoxin.

ACE Inhibitors

ACE inhibitors (lisinopril, enalapril, ramipril, benazepril) block the angiotensin-converting enzyme, which converts angiotensin I to angiotensin II — a potent vasoconstrictor. By reducing angiotensin II levels, these drugs relax blood vessels, lower aldosterone secretion (reducing sodium retention), and decrease the workload on the heart.

ACE inhibitors are particularly well-suited for patients with diabetes, chronic kidney disease, or heart failure, because they slow the progression of kidney damage and reduce cardiac remodeling. The HOPE trial demonstrated that ramipril reduced the risk of myocardial infarction, stroke, and cardiovascular death by 22% in high-risk patients.

Common side effects: Dry cough (affects 5-20% of patients and is the most common reason for switching), elevated potassium, dizziness. Rarely, angioedema — swelling of the face, lips, or throat — which requires immediate discontinuation. ACE inhibitors are contraindicated in pregnancy.

Angiotensin Receptor Blockers (ARBs)

ARBs (losartan, valsartan, irbesartan, olmesartan) target the same hormonal pathway as ACE inhibitors but at a different point. Instead of blocking the enzyme that produces angiotensin II, they block the receptor where angiotensin II binds. The result is similar — vasodilation and reduced aldosterone — but without the cough that plagues many ACE inhibitor users, because ARBs do not increase bradykinin levels.

ARBs are often prescribed when patients cannot tolerate ACE inhibitors. The LIFE trial showed that losartan was superior to atenolol (a beta-blocker) in reducing stroke risk among hypertensive patients with left ventricular hypertrophy.

Common side effects: Dizziness, elevated potassium, headache. Generally well tolerated. Like ACE inhibitors, ARBs are contraindicated in pregnancy. ACE inhibitors and ARBs should not be used together.

Calcium Channel Blockers

Calcium channel blockers (amlodipine, nifedipine, diltiazem, verapamil) reduce blood pressure by preventing calcium from entering the smooth muscle cells of blood vessel walls. Without calcium influx, the muscles relax and the vessels dilate. Dihydropyridines like amlodipine primarily affect blood vessels, while non-dihydropyridines like diltiazem and verapamil also slow the heart rate.

Amlodipine is one of the most widely prescribed antihypertensives in the world. It has a long half-life, allowing once-daily dosing, and is effective across age groups and racial demographics. Clinical data suggest calcium channel blockers are particularly effective in Black patients and older adults, populations in which the renin-angiotensin system may play a less dominant role in blood pressure regulation.

Common side effects: Peripheral edema (swelling of the ankles and feet, especially with amlodipine), flushing, headache, constipation (particularly with verapamil). The ankle swelling is not a sign of heart failure — it results from local vasodilation — but it can be uncomfortable enough to warrant switching medications.

Second-Line and Add-On Medications

Beta-Blockers

Beta-blockers (metoprolol, atenolol, carvedilol, propranolol) reduce blood pressure by slowing the heart rate and decreasing the force of contraction. They also reduce renin release from the kidneys. While they were once considered first-line therapy, several large trials and meta-analyses — including a Cochrane review — found them less effective than other classes at preventing stroke, particularly in older adults.

The current guidelines position beta-blockers as add-on therapy or as preferred agents in specific situations: post-heart attack, heart failure with reduced ejection fraction, atrial fibrillation rate control, or patients with high sympathetic tone (rapid heart rate, anxiety-related blood pressure spikes).

Common side effects: Fatigue, cold hands and feet, weight gain, depression, erectile dysfunction, bradycardia. Beta-blockers should not be stopped abruptly, as this can cause rebound hypertension or tachycardia.

Aldosterone Antagonists

Spironolactone and eplerenone block aldosterone, a hormone that promotes sodium and water retention. These drugs are particularly useful in resistant hypertension — blood pressure that remains uncontrolled despite three or more medications. The PATHWAY-2 trial demonstrated that spironolactone was significantly more effective than bisoprolol or doxazosin as a fourth-line agent for resistant hypertension.

Common side effects: Elevated potassium (requires monitoring), gynecomastia and breast tenderness with spironolactone (less so with eplerenone), menstrual irregularities.

Combination Therapy

Most patients with Stage 2 hypertension will need two or more medications to reach their blood pressure target. The guidelines recommend starting with two drugs when blood pressure is 20/10 mmHg or more above goal. Certain combinations are preferred because they work through complementary mechanisms:

• ACE inhibitor or ARB + calcium channel blocker
• ACE inhibitor or ARB + thiazide diuretic
• Calcium channel blocker + thiazide diuretic

Fixed-dose combination pills (two drugs in one tablet) improve adherence because they reduce the number of pills taken daily. A meta-analysis in The Lancet found that adherence to antihypertensive therapy drops by roughly 10% for each additional daily dose.

Choosing the Right Medication

Condition	Preferred Class
Diabetes with proteinuria	ACE inhibitor or ARB
Heart failure	ACE inhibitor/ARB + beta-blocker + diuretic
Post-myocardial infarction	Beta-blocker + ACE inhibitor
Chronic kidney disease	ACE inhibitor or ARB
Older adults / isolated systolic HTN	Thiazide or calcium channel blocker
Resistant hypertension	Add spironolactone

Adherence: The Biggest Challenge

The World Health Organization estimates that only about 50% of patients with chronic conditions take their medications as prescribed. For hypertension, this is particularly problematic because the condition is usually asymptomatic. People feel fine, so they skip doses or stop altogether — and the consequences may not appear for years.

If side effects are the reason for nonadherence, that is a solvable problem. There are enough medication options that most patients can find a regimen they tolerate well. The conversation with your doctor about side effects is not a complaint; it is clinically important information that guides treatment decisions.